John F Atkins

Title: John F Atkins: Innovator in Arterivirus Research

Introduction

John F Atkins is a notable inventor based in Cork, Ireland. He has made significant contributions to the field of virology, particularly in the study of arteriviruses. His work has implications for understanding viral replication and developing potential vaccines.

Latest Patents

Atkins holds a patent for his invention titled "Arterivirus protein and expression mechanisms." This patent describes the discovery and characterization of a novel arterivirus protein known as nsp2TF. The expression of this protein is dependent on -2 ribosomal frameshifting at a specific site within the nsp2 coding region. The unique TF domain of nsp2TF overlaps with the transmembrane region of nsp2 in various arteriviruses, including Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Lactate Dehydrogenase Virus (LDV), and Simian Hemorrhagic Fever Virus (SHFV). His research indicates that mutations affecting the expression of nsp2TF can impair PRRSV replication and lead to a smaller plaque phenotype. The patent also provides methods for identifying compounds that inhibit -2 frameshifting and tools for gene expression in eukaryotic systems.

Career Highlights

Throughout his career, John F Atkins has worked with prestigious institutions, including the University of Cambridge and Academisch Ziekenhuis Leiden. His research has contributed to advancements in understanding viral mechanisms and potential therapeutic approaches.

Collaborations

Atkins has collaborated with notable colleagues, including Emma Elisabeth Treffers and Ali Tas. Their combined expertise has furthered research in the field of virology.

Conclusion

John F Atkins is a prominent inventor whose work on arterivirus proteins has the potential to impact vaccine development and diagnostic methods. His contributions to virology continue to be recognized in the scientific community.